CESC patients with high SERPINH1 expression exhibited widespread suppression of lipid metabolism, yet selectively activated the unsaturated fatty acid synthesis pathway, which may be an adaptation to the metabolic demands of tumor metastasis [34]. The gene discussed is SERPINH1; the disease is cervical squamous cell carcinoma.